Hermetica Superfood Encyclopedia
The Short Answer
Melochia odorata leaves contain the cyclic peptide alkaloid frangulanine and the quinolinone alkaloid waltherione-A, alongside high concentrations of phenolics (up to 182.26 mg GAE/g) and flavonoids (up to 128.57 mg QE/g) that collectively underlie its antifungal, antioxidant, and antidiabetic activities in laboratory assays. Methanol leaf extract (CLM) demonstrated the most potent in vitro antioxidant activity with a DPPH IC50 of 32.81 ± 5.26 µg/mL and inhibited α-glucosidase with an IC50 of 249.50 ± 0.97 µg/mL, though no human clinical data exist to confirm these effects.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordMelochia odorata benefits
Melochia odorata — botanical close-up
Health Benefits
**Antifungal Activity**
Alkaloids frangulanine and waltherione-A, isolated via bioassay-guided HPLC fractionation, demonstrated inhibitory activity against Candida albicans, Cryptococcus neoformans, and Saccharomyces cerevisiae in TLC bioautography assays, suggesting these cyclic peptide and quinolinone alkaloids disrupt fungal membrane or metabolic integrity.
**Antioxidant Capacity**
Methanol leaf extract (CLM) exhibited potent DPPH free radical scavenging with an IC50 of 32.81 ± 5.26 µg/mL, an activity attributed to its exceptionally high total phenolic content (182.26 ± 1.99 mg GAE/g) and total flavonoid content (128.57 ± 7.62 mg QE/g), positioning it among phenolic-rich botanicals in in vitro comparisons.
**Antidiabetic Potential**: Both methanol leaf (CLM, IC50 249
50 ± 0.97 µg/mL) and flower (CFM, IC50 227.63 ± 11.38 µg/mL) extracts inhibited α-glucosidase activity in vitro, an enzyme responsible for postprandial glucose release, suggesting a potential mechanism for blood sugar modulation analogous to pharmaceutical alpha-glucosidase inhibitors.
**Antibacterial Properties**
Extracts with higher flavonoid and alkaloid concentrations demonstrated antibacterial effects in preliminary in vitro bioassays, with leaf and flower preparations outperforming stem extracts, likely reflecting the higher total phenolic and flavonoid content measured in aerial photosynthetic tissues.
**Traditional Use for Splenomegaly**
In Papua New Guinean ethnomedicine, Melochia odorata is employed as a remedy for enlarged spleen (splenomegaly), representing a documented traditional therapeutic application that has not yet been mechanistically validated through phytochemical or pharmacological investigation specific to splenic tissue.
**Cytotoxic Activity**
Aqueous leaf extract demonstrated brine shrimp lethality with an LC50 of 830.09 ± 115.57 µg/mL, indicating moderate cytotoxic potential attributed to the combined presence of alkaloids, terpenoids, and polyphenols, a finding that warrants further investigation for potential selective cytotoxicity toward abnormal cell types.
**Phenolic-Rich Nutritional Profile**
The plant's leaves and flowers contain among the highest recorded total phenolic and flavonoid concentrations documented in Pacific Island Malvaceae species, suggesting potential as a source of dietary antioxidants, though no formal nutritional intake or bioavailability studies in humans have been conducted.
Origin & History
Natural habitat
Melochia odorata is a flowering plant in the family Malvaceae (formerly Sterculiaceae) distributed across tropical regions of the Pacific Islands, Southeast Asia, and parts of Africa, thriving in humid lowland environments, forest margins, and disturbed vegetation. It is particularly associated with Papua New Guinea and surrounding Pacific Island nations, where it grows in secondary growth forests and along roadsides at low to mid elevations. The plant has not been subjected to formal agricultural cultivation and is primarily harvested from wild stands for local traditional medicinal use.
“Melochia odorata holds a documented place in the traditional healing practices of Papua New Guinea, where it is used specifically for the treatment of enlarged spleen (splenomegaly), a condition commonly associated with chronic malaria infection in tropical Pacific populations, suggesting the plant may have been empirically selected for use in malaria-endemic communities where splenomegaly is prevalent. The plant's vernacular use in the Pacific Islands reflects a broader regional tradition of employing Malvaceae family plants for inflammation-related and systemic conditions, though Melochia odorata specifically has not been prominently featured in major historical pharmacopoeias or colonial-era botanical medicine compilations. Traditional preparation methods are not elaborated in the available scientific literature, but the ethnobotanical context implies whole-plant or leaf-based preparations administered orally, consistent with decoction practices common to Pacific Island traditional medicine systems. The species' fragrant character (reflected in the epithet 'odorata') may have contributed to its cultural selection and use, though no formal organoleptic or aromatic compound studies have been published.”Traditional Medicine
Scientific Research
The scientific evidence base for Melochia odorata is limited to a small number of in vitro laboratory studies, with no published randomized controlled trials, observational studies, or any human clinical data identified in the peer-reviewed literature. Two principal lines of investigation exist: a bioassay-guided phytochemical study isolating antifungal alkaloids (frangulanine and waltherione-A) via HPLC fractionation from leaf extracts, and a multi-extract comparative study quantifying total phenolic content, total flavonoid content, DPPH radical scavenging, α-glucosidase inhibition, antibacterial activity, and brine shrimp cytotoxicity across leaf, flower, and stem fractions. These studies provide internally consistent data showing that methanol leaf and flower extracts consistently outperform stem extracts in all bioassays tested, but the evidence quality is rated very low by conventional clinical standards (e.g., GRADE framework) due to exclusive reliance on cell-free and invertebrate model systems. Extrapolation of these findings to human therapeutic applications, including the traditional use for splenomegaly, is not scientifically supported without animal model studies and subsequent clinical investigation.
Preparation & Dosage
Traditional preparation
**Traditional Aqueous Decoction (Papua New Guinea)**
Leaves are prepared as a decoction for traditional use in enlarged spleen conditions; no standardized volume, concentration, or dosing frequency has been documented in the ethnobotanical or clinical literature.
**Methanol Leaf Extract (Research Use Only)**
Used in laboratory studies at concentrations of 32–250 µg/mL for in vitro bioassays; not applicable to human supplementation and not commercially available in standardized form.
**Methanol Flower Extract (Research Use Only)**
Demonstrated similar activity to leaf extract in antioxidant and antidiabetic assays at comparable in vitro concentrations; no human dose established.
**Alkaloidal Leaf Extract (Research Use Only)**
Fractionated via HPLC for isolation of frangulanine and waltherione-A; no standardization percentage or supplement form exists.
**Standardization**
No standardized extracts (e.g., standardized to a specific percentage of frangulanine, waltherione-A, or total phenolics) are commercially produced or clinically validated.
**Important Note**
No safe or effective supplemental dose has been established for any preparation of Melochia odorata in humans; use outside traditional ethnomedicinal contexts should not occur without formal clinical evaluation.
Nutritional Profile
Formal proximate nutritional analysis of Melochia odorata has not been published; however, phytochemical profiling reveals a phenolic-rich composition with methanol leaf extracts containing total phenolic content of 182.26 ± 1.99 mg GAE/g and total flavonoid content of 128.57 ± 7.62 mg QE/g, values which are exceptionally high and indicate dense flavonoid and hydroxycinnamic acid contributions. Flower extracts similarly show TPC of 172.65 ± 0.48 mg GAE/g and TFC of 121.74 ± 7.06 mg QE/g, while stem extracts are lower (TPC: 113.6 ± 3.51 mg GAE/g), indicating a leaf-and-flower-dominant phytochemical gradient. The alkaloid fraction contributes frangulanine (cyclic peptide class) and waltherione-A (quinolinone class), with terpenoids also implicated in cytotoxicity assays, though individual terpenoid compounds have not been isolated or quantified. Macronutrient composition (protein, fat, carbohydrate, fiber), micronutrient content (vitamins, minerals), and bioavailability of any constituent following oral ingestion remain entirely uncharacterized.
How It Works
Mechanism of Action
The antifungal activity of Melochia odorata is primarily attributed to frangulanine, a cyclic peptide alkaloid, and waltherione-A, a quinolinone alkaloid, which are believed to interfere with fungal cell membrane integrity or ergosterol biosynthesis pathways, consistent with the known mechanisms of structurally related alkaloids against Candida and Cryptococcus species, as demonstrated in TLC bioautography assays. The antioxidant mechanism is driven by the dense concentration of phenolic hydroxyl groups present in leaf and flower flavonoids, which donate hydrogen atoms to neutralize DPPH and likely other reactive oxygen species through single-electron transfer and hydrogen atom transfer pathways, explaining the strong correlation between total phenolic content and IC50 values across plant parts. Alpha-glucosidase inhibition by leaf and flower extracts is consistent with competitive or mixed-mode inhibition by flavonoid aglycones and their glycosides, which are known to occupy the active site of this intestinal brush-border enzyme, thereby slowing the hydrolysis of oligosaccharides and reducing postprandial glucose absorption. No receptor-level binding studies, gene expression analyses, or defined intracellular signaling pathway interactions have been published for any Melochia odorata extract or isolated compound, representing a critical gap in mechanistic understanding.
Clinical Evidence
No clinical trials of any phase have been conducted on Melochia odorata in human subjects, and no animal pharmacological studies were identified in the available literature, meaning there are no human effect sizes, safety endpoints, or pharmacokinetic parameters to report. The entirety of quantitative biological data derives from in vitro assays: DPPH IC50 (CLM: 32.81 µg/mL), α-glucosidase IC50 (CLM: 249.50 µg/mL; CFM: 227.63 µg/mL), antifungal TLC bioautography against three fungal species, and brine shrimp lethality LC50 (aqueous: 830.09 µg/mL). These in vitro metrics suggest biological activity but cannot be used to establish therapeutic doses, predict clinical efficacy, or assess human safety, as in vitro potency frequently does not translate to equivalent in vivo activity due to bioavailability, metabolism, and systemic distribution variables. Confidence in any clinical application is therefore extremely low, and the plant should be regarded strictly as a subject of preliminary ethnopharmacological and phytochemical research.
Safety & Interactions
Human safety data for Melochia odorata do not exist in the published literature; the only toxicity metric available is an in vitro brine shrimp lethality LC50 of 830.09 ± 115.57 µg/mL for aqueous leaf extract, which indicates moderate cytotoxic potential and is higher than a previously reported value of 392 µg/mL, reflecting assay variability and cautioning against assumptions of safety at higher concentrations. The presence of alkaloids (frangulanine, waltherione-A) and terpenoids with demonstrated cytotoxic activity in brine shrimp models raises theoretical concern for hepatotoxicity, nephrotoxicity, or other systemic effects at doses relevant to human consumption, though this has not been studied in mammalian models. No drug interaction data are available; however, the α-glucosidase inhibitory activity observed in vitro raises a theoretical concern for additive hypoglycemic effects if co-administered with antidiabetic medications such as acarbose, metformin, or insulin, warranting caution in diabetic individuals. Guidance for use during pregnancy, lactation, or in pediatric populations cannot be provided due to complete absence of reproductive or developmental toxicity data, and use in these populations is not advisable until formal safety studies are completed.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Melochia odorata (Malvaceae)Melochia odorata L.Pacific Islands spleen herbodorous melochiaMelochia odorata (Melochia odorata L.f.)
Frequently Asked Questions
What is Melochia odorata traditionally used for?
In Papua New Guinea, Melochia odorata is traditionally used as a remedy for enlarged spleen (splenomegaly), a condition commonly associated with chronic malaria infection in tropical Pacific Island populations. This represents an ethnomedicinal application documented in ethnobotanical surveys, but it has not been validated through pharmacological or clinical research specifically targeting splenic tissue or splenomegaly mechanisms.
What bioactive compounds are found in Melochia odorata?
The leaves of Melochia odorata contain two principal alkaloids: frangulanine, a cyclic peptide alkaloid, and waltherione-A, a quinolinone alkaloid, both isolated via bioassay-guided HPLC fractionation and associated with antifungal activity. The leaves and flowers also contain exceptionally high total phenolic content (up to 182.26 mg GAE/g) and total flavonoid content (up to 128.57 mg QE/g) in methanol extracts, which underlie the plant's antioxidant and alpha-glucosidase inhibitory activities measured in laboratory assays.
Does Melochia odorata have antifungal properties?
Laboratory studies using TLC bioautography have shown that alkaloid fractions of Melochia odorata leaf extracts, specifically containing frangulanine and waltherione-A, inhibit the growth of Candida albicans, Cryptococcus neoformans, and Saccharomyces cerevisiae. However, these findings are limited to in vitro assays, and no minimum inhibitory concentration values, animal model studies, or clinical trials have been conducted to confirm antifungal efficacy in living organisms.
Is Melochia odorata safe to consume?
No formal human safety evaluation of Melochia odorata has been published; the only available toxicity data is a brine shrimp lethality LC50 of 830.09 µg/mL for aqueous leaf extract, indicating moderate in vitro cytotoxic potential attributable to alkaloids and terpenoids. The presence of pharmacologically active alkaloids raises theoretical concerns about systemic toxicity at higher doses, and no safe human dose, drug interaction profile, or contraindication list has been established, making it inadvisable to use outside of traditional ethnomedicinal contexts without medical supervision.
What is the antioxidant activity of Melochia odorata?
Methanol leaf extract (CLM) of Melochia odorata demonstrated potent DPPH free radical scavenging activity with an IC50 of 32.81 ± 5.26 µg/mL in in vitro assays, which correlates with its high total phenolic content of 182.26 ± 1.99 mg GAE/g and total flavonoid content of 128.57 ± 7.62 mg QE/g. While these values indicate strong antioxidant capacity in cell-free laboratory systems, no human bioavailability studies or clinical antioxidant biomarker trials have been performed to determine whether this activity translates to meaningful antioxidant effects in the human body.
How does Melochia odorata compare to other antifungal herbs like oregano or tea tree oil?
Melochia odorata contains specific alkaloids (frangulanine and waltherione-A) that have demonstrated inhibitory activity against multiple fungal species including Candida albicans and Cryptococcus neoformans in laboratory bioassays. Unlike oregano and tea tree oil, which are more established in traditional use, Melochia odorata's antifungal mechanism appears to work through disruption of fungal membrane and metabolic integrity at the molecular level. The comparative efficacy in human clinical trials remains limited, making direct effectiveness comparisons premature at this stage of research.
What is the most bioavailable or effective form of Melochia odorata supplement?
Melochia odorata's bioactive alkaloids have been successfully isolated via HPLC fractionation methods, suggesting that standardized extracts targeting these compounds may offer concentrated efficacy compared to whole-herb preparations. However, clinical data on bioavailability and absorption of different forms (extracts, powders, or decoctions) in human subjects is currently lacking. Traditional preparations typically involve infusions or decoctions, though standardized extracts would theoretically provide more consistent alkaloid content.
What does current research show about Melochia odorata's effectiveness in humans versus laboratory studies?
Most research on Melochia odorata has been conducted in vitro using TLC bioautography assays and laboratory cultures of fungal species, demonstrating promising antimicrobial and antioxidant properties at the cellular level. Rigorous clinical trials in human subjects are currently limited, meaning efficacy claims remain largely based on traditional use and preliminary laboratory evidence rather than controlled human studies. Additional research is needed to establish effective dosages, bioavailability, and clinical outcomes in human populations.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w melochia-odorata-melochia-odorata-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
